TP53 and ovarian cancer: Under cisplatin treatment at a dose of 2 μg/mL, the protein level of p53 in A2780 cells was increased in a time-dependent manner, but the p53 protein level in SKOV3 cells did not significantly change, indicating that p53 might be related to ovarian cancer cell cisplatin sensitivity (Figure 1c).